The global market for Infectious Disease In-vitro Diagnostic was estimated to be worth US$ 56 million in 2023 and is forecast to a readjusted size of US$ 85 million by 2030 with a CAGR of 3.9% during the forecast period 2024-2030

Infectious Disease In-vitro Diagnostic - Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Infectious Disease In-vitro Diagnostic, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Infectious Disease In-vitro Diagnostic by region & country, by Type, and by Application.

The Infectious Disease In-vitro Diagnostic market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Disease In-vitro Diagnostic.

Market Segmentation

Scope of Infectious Disease In-vitro Diagnostic - Market Report

Report Metric	Details
Report Name	Infectious Disease In-vitro Diagnostic - Market
Forecasted market size in 2030	US$ 85 million
CAGR	3.9%
Forecasted years	2024 - 2030
Segment by Type:	Immunoassay Molecular Diagnostics Microbiology Others
Segment by Application	COVID-19 MRSA Clostridium Difficile Respiratory Virus TB and Drug-resistant TB Chlamydia Gonorrhea HPV HIV Others(Gastro-intestinal Panel Testing, Hepatitis C, Hepatitis B, etc)
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	BD, BioMérieux SA, Abbott, Quidel Corporation, OraSure Technologies, Inc., Hologic, Inc. (Gen Probe), Danaher, QIAGEN, Roche, Siemens Healthineers AG, Bio-Rad Laboratories, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Infectious Disease In-vitro Diagnostic manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Infectious Disease In-vitro Diagnostic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Infectious Disease In-vitro Diagnostic in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Infectious Disease In-vitro Diagnostic - Market size in 2030?

Ans: The Infectious Disease In-vitro Diagnostic - Market size in 2030 will be US$ 85 million.

Who are the main players in the Infectious Disease In-vitro Diagnostic - Market report?

Ans: The main players in the Infectious Disease In-vitro Diagnostic - Market are BD, BioMérieux SA, Abbott, Quidel Corporation, OraSure Technologies, Inc., Hologic, Inc. (Gen Probe), Danaher, QIAGEN, Roche, Siemens Healthineers AG, Bio-Rad Laboratories, Inc.

What are the Application segmentation covered in the Infectious Disease In-vitro Diagnostic - Market report?

Ans: The Applications covered in the Infectious Disease In-vitro Diagnostic - Market report are COVID-19, MRSA, Clostridium Difficile, Respiratory Virus, TB and Drug-resistant TB, Chlamydia, Gonorrhea, HPV, HIV, Others(Gastro-intestinal Panel Testing, Hepatitis C, Hepatitis B, etc)

What are the Type segmentation covered in the Infectious Disease In-vitro Diagnostic - Market report?

Ans: The Types covered in the Infectious Disease In-vitro Diagnostic - Market report are Immunoassay, Molecular Diagnostics, Microbiology, Others

1 Market Overview

1.1 Infectious Disease In-vitro Diagnostic Product Introduction

1.2 Global Infectious Disease In-vitro Diagnostic Market Size Forecast

1.3 Infectious Disease In-vitro Diagnostic Market Trends & Drivers

1.3.1 Infectious Disease In-vitro Diagnostic Industry Trends

1.3.2 Infectious Disease In-vitro Diagnostic Market Drivers & Opportunity

1.3.3 Infectious Disease In-vitro Diagnostic Market Challenges

1.3.4 Infectious Disease In-vitro Diagnostic Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Infectious Disease In-vitro Diagnostic Players Revenue Ranking (2023)

2.2 Global Infectious Disease In-vitro Diagnostic Revenue by Company (2019-2024)

2.3 Key Companies Infectious Disease In-vitro Diagnostic Manufacturing Base Distribution and Headquarters

2.4 Key Companies Infectious Disease In-vitro Diagnostic Product Offered

2.5 Key Companies Time to Begin Mass Production of Infectious Disease In-vitro Diagnostic

2.6 Infectious Disease In-vitro Diagnostic Market Competitive Analysis

2.6.1 Infectious Disease In-vitro Diagnostic Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Infectious Disease In-vitro Diagnostic Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease In-vitro Diagnostic as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Immunoassay

3.1.2 Molecular Diagnostics

3.1.3 Microbiology

3.1.4 Others

3.2 Global Infectious Disease In-vitro Diagnostic Sales Value by Type

3.2.1 Global Infectious Disease In-vitro Diagnostic Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Infectious Disease In-vitro Diagnostic Sales Value, by Type (2019-2030)

3.2.3 Global Infectious Disease In-vitro Diagnostic Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 COVID-19

4.1.2 MRSA

4.1.3 Clostridium Difficile

4.1.4 Respiratory Virus

4.1.5 TB and Drug-resistant TB

4.1.6 Chlamydia

4.1.7 Gonorrhea

4.1.8 HPV

4.1.9 HIV

4.1.10 Others(Gastro-intestinal Panel Testing, Hepatitis C, Hepatitis B, etc)

4.2 Global Infectious Disease In-vitro Diagnostic Sales Value by Application

4.2.1 Global Infectious Disease In-vitro Diagnostic Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Infectious Disease In-vitro Diagnostic Sales Value, by Application (2019-2030)

4.2.3 Global Infectious Disease In-vitro Diagnostic Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Infectious Disease In-vitro Diagnostic Sales Value by Region

5.1.1 Global Infectious Disease In-vitro Diagnostic Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Infectious Disease In-vitro Diagnostic Sales Value by Region (2019-2024)

5.1.3 Global Infectious Disease In-vitro Diagnostic Sales Value by Region (2025-2030)

5.1.4 Global Infectious Disease In-vitro Diagnostic Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Infectious Disease In-vitro Diagnostic Sales Value, 2019-2030

5.2.2 North America Infectious Disease In-vitro Diagnostic Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Infectious Disease In-vitro Diagnostic Sales Value, 2019-2030

5.3.2 Europe Infectious Disease In-vitro Diagnostic Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Infectious Disease In-vitro Diagnostic Sales Value, 2019-2030

5.4.2 Asia Pacific Infectious Disease In-vitro Diagnostic Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Infectious Disease In-vitro Diagnostic Sales Value, 2019-2030

5.5.2 South America Infectious Disease In-vitro Diagnostic Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Infectious Disease In-vitro Diagnostic Sales Value, 2019-2030

5.6.2 Middle East & Africa Infectious Disease In-vitro Diagnostic Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Infectious Disease In-vitro Diagnostic Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Infectious Disease In-vitro Diagnostic Sales Value

6.3 United States

6.3.1 United States Infectious Disease In-vitro Diagnostic Sales Value, 2019-2030

6.3.2 United States Infectious Disease In-vitro Diagnostic Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Infectious Disease In-vitro Diagnostic Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Infectious Disease In-vitro Diagnostic Sales Value, 2019-2030

6.4.2 Europe Infectious Disease In-vitro Diagnostic Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Infectious Disease In-vitro Diagnostic Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Infectious Disease In-vitro Diagnostic Sales Value, 2019-2030

6.5.2 China Infectious Disease In-vitro Diagnostic Sales Value by Type (%), 2023 VS 2030

6.5.3 China Infectious Disease In-vitro Diagnostic Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Infectious Disease In-vitro Diagnostic Sales Value, 2019-2030

6.6.2 Japan Infectious Disease In-vitro Diagnostic Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Infectious Disease In-vitro Diagnostic Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Infectious Disease In-vitro Diagnostic Sales Value, 2019-2030

6.7.2 South Korea Infectious Disease In-vitro Diagnostic Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Infectious Disease In-vitro Diagnostic Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Infectious Disease In-vitro Diagnostic Sales Value, 2019-2030

6.8.2 Southeast Asia Infectious Disease In-vitro Diagnostic Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Infectious Disease In-vitro Diagnostic Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Infectious Disease In-vitro Diagnostic Sales Value, 2019-2030

6.9.2 India Infectious Disease In-vitro Diagnostic Sales Value by Type (%), 2023 VS 2030

6.9.3 India Infectious Disease In-vitro Diagnostic Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 BD

7.1.1 BD Profile

7.1.2 BD Main Business

7.1.3 BD Infectious Disease In-vitro Diagnostic Products, Services and Solutions

7.1.4 BD Infectious Disease In-vitro Diagnostic Revenue (US$ Million) & (2019-2024)

7.1.5 BD Recent Developments

7.2 BioMérieux SA

7.2.1 BioMérieux SA Profile

7.2.2 BioMérieux SA Main Business

7.2.3 BioMérieux SA Infectious Disease In-vitro Diagnostic Products, Services and Solutions

7.2.4 BioMérieux SA Infectious Disease In-vitro Diagnostic Revenue (US$ Million) & (2019-2024)

7.2.5 BioMérieux SA Recent Developments

7.3 Abbott

7.3.1 Abbott Profile

7.3.2 Abbott Main Business

7.3.3 Abbott Infectious Disease In-vitro Diagnostic Products, Services and Solutions

7.3.4 Abbott Infectious Disease In-vitro Diagnostic Revenue (US$ Million) & (2019-2024)

7.3.5 Quidel Corporation Recent Developments

7.4 Quidel Corporation

7.4.1 Quidel Corporation Profile

7.4.2 Quidel Corporation Main Business

7.4.3 Quidel Corporation Infectious Disease In-vitro Diagnostic Products, Services and Solutions

7.4.4 Quidel Corporation Infectious Disease In-vitro Diagnostic Revenue (US$ Million) & (2019-2024)

7.4.5 Quidel Corporation Recent Developments

7.5 OraSure Technologies, Inc.

7.5.1 OraSure Technologies, Inc. Profile

7.5.2 OraSure Technologies, Inc. Main Business

7.5.3 OraSure Technologies, Inc. Infectious Disease In-vitro Diagnostic Products, Services and Solutions

7.5.4 OraSure Technologies, Inc. Infectious Disease In-vitro Diagnostic Revenue (US$ Million) & (2019-2024)

7.5.5 OraSure Technologies, Inc. Recent Developments

7.6 Hologic, Inc. (Gen Probe)

7.6.1 Hologic, Inc. (Gen Probe) Profile

7.6.2 Hologic, Inc. (Gen Probe) Main Business

7.6.3 Hologic, Inc. (Gen Probe) Infectious Disease In-vitro Diagnostic Products, Services and Solutions

7.6.4 Hologic, Inc. (Gen Probe) Infectious Disease In-vitro Diagnostic Revenue (US$ Million) & (2019-2024)

7.6.5 Hologic, Inc. (Gen Probe) Recent Developments

7.7 Danaher

7.7.1 Danaher Profile

7.7.2 Danaher Main Business

7.7.3 Danaher Infectious Disease In-vitro Diagnostic Products, Services and Solutions

7.7.4 Danaher Infectious Disease In-vitro Diagnostic Revenue (US$ Million) & (2019-2024)

7.7.5 Danaher Recent Developments

7.8 QIAGEN

7.8.1 QIAGEN Profile

7.8.2 QIAGEN Main Business

7.8.3 QIAGEN Infectious Disease In-vitro Diagnostic Products, Services and Solutions

7.8.4 QIAGEN Infectious Disease In-vitro Diagnostic Revenue (US$ Million) & (2019-2024)

7.8.5 QIAGEN Recent Developments

7.9 Roche

7.9.1 Roche Profile

7.9.2 Roche Main Business

7.9.3 Roche Infectious Disease In-vitro Diagnostic Products, Services and Solutions

7.9.4 Roche Infectious Disease In-vitro Diagnostic Revenue (US$ Million) & (2019-2024)

7.9.5 Roche Recent Developments

7.10 Siemens Healthineers AG

7.10.1 Siemens Healthineers AG Profile

7.10.2 Siemens Healthineers AG Main Business

7.10.3 Siemens Healthineers AG Infectious Disease In-vitro Diagnostic Products, Services and Solutions

7.10.4 Siemens Healthineers AG Infectious Disease In-vitro Diagnostic Revenue (US$ Million) & (2019-2024)

7.10.5 Siemens Healthineers AG Recent Developments

7.11 Bio-Rad Laboratories, Inc.

7.11.1 Bio-Rad Laboratories, Inc. Profile

7.11.2 Bio-Rad Laboratories, Inc. Main Business

7.11.3 Bio-Rad Laboratories, Inc. Infectious Disease In-vitro Diagnostic Products, Services and Solutions

7.11.4 Bio-Rad Laboratories, Inc. Infectious Disease In-vitro Diagnostic Revenue (US$ Million) & (2019-2024)

7.11.5 Bio-Rad Laboratories, Inc. Recent Developments

8 Industry Chain Analysis

8.1 Infectious Disease In-vitro Diagnostic Industrial Chain

8.2 Infectious Disease In-vitro Diagnostic Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Infectious Disease In-vitro Diagnostic Sales Model

8.5.2 Sales Channel

8.5.3 Infectious Disease In-vitro Diagnostic Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

BioMérieux SA

Abbott

Quidel Corporation

Orasure Technologies, Inc.

Danaher

Qiagen NV

Roche

Siemens Healthineers AG

Bio-Rad Laboratories Inc

Hologic, Inc. (Gen Probe)

List of Tables

Table 1. Infectious Disease In-vitro Diagnostic Market Trends

Table 2. Infectious Disease In-vitro Diagnostic Market Drivers & Opportunity

Table 3. Infectious Disease In-vitro Diagnostic Market Challenges

Table 4. Infectious Disease In-vitro Diagnostic Market Restraints

Table 5. Global Infectious Disease In-vitro Diagnostic Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Infectious Disease In-vitro Diagnostic Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Infectious Disease In-vitro Diagnostic Product Type

Table 9. Key Companies Time to Begin Mass Production of Infectious Disease In-vitro Diagnostic

Table 10. Global Infectious Disease In-vitro Diagnostic Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease In-vitro Diagnostic as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Infectious Disease In-vitro Diagnostic Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Infectious Disease In-vitro Diagnostic Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Infectious Disease In-vitro Diagnostic Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Infectious Disease In-vitro Diagnostic Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Infectious Disease In-vitro Diagnostic Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Infectious Disease In-vitro Diagnostic Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Infectious Disease In-vitro Diagnostic Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Infectious Disease In-vitro Diagnostic Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Infectious Disease In-vitro Diagnostic Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Infectious Disease In-vitro Diagnostic Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Infectious Disease In-vitro Diagnostic Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Infectious Disease In-vitro Diagnostic Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Infectious Disease In-vitro Diagnostic Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Infectious Disease In-vitro Diagnostic Sales Value by Region (2019-2024) & (%)

Table 27. Global Infectious Disease In-vitro Diagnostic Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Infectious Disease In-vitro Diagnostic Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Infectious Disease In-vitro Diagnostic Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Infectious Disease In-vitro Diagnostic Sales Value, (2025-2030) & (US$ Million)

Table 31. BD Basic Information List

Table 32. BD Description and Business Overview

Table 33. BD Infectious Disease In-vitro Diagnostic Products, Services and Solutions

Table 34. Revenue (US$ Million) in Infectious Disease In-vitro Diagnostic Business of BD (2019-2024)

Table 35. BD Recent Developments

Table 36. BioMérieux SA Basic Information List

Table 37. BioMérieux SA Description and Business Overview

Table 38. BioMérieux SA Infectious Disease In-vitro Diagnostic Products, Services and Solutions

Table 39. Revenue (US$ Million) in Infectious Disease In-vitro Diagnostic Business of BioMérieux SA (2019-2024)

Table 40. BioMérieux SA Recent Developments

Table 41. Abbott Basic Information List

Table 42. Abbott Description and Business Overview

Table 43. Abbott Infectious Disease In-vitro Diagnostic Products, Services and Solutions

Table 44. Revenue (US$ Million) in Infectious Disease In-vitro Diagnostic Business of Abbott (2019-2024)

Table 45. Abbott Recent Developments

Table 46. Quidel Corporation Basic Information List

Table 47. Quidel Corporation Description and Business Overview

Table 48. Quidel Corporation Infectious Disease In-vitro Diagnostic Products, Services and Solutions

Table 49. Revenue (US$ Million) in Infectious Disease In-vitro Diagnostic Business of Quidel Corporation (2019-2024)

Table 50. Quidel Corporation Recent Developments

Table 51. OraSure Technologies, Inc. Basic Information List

Table 52. OraSure Technologies, Inc. Description and Business Overview

Table 53. OraSure Technologies, Inc. Infectious Disease In-vitro Diagnostic Products, Services and Solutions

Table 54. Revenue (US$ Million) in Infectious Disease In-vitro Diagnostic Business of OraSure Technologies, Inc. (2019-2024)

Table 55. OraSure Technologies, Inc. Recent Developments

Table 56. Hologic, Inc. (Gen Probe) Basic Information List

Table 57. Hologic, Inc. (Gen Probe) Description and Business Overview

Table 58. Hologic, Inc. (Gen Probe) Infectious Disease In-vitro Diagnostic Products, Services and Solutions

Table 59. Revenue (US$ Million) in Infectious Disease In-vitro Diagnostic Business of Hologic, Inc. (Gen Probe) (2019-2024)

Table 60. Hologic, Inc. (Gen Probe) Recent Developments

Table 61. Danaher Basic Information List

Table 62. Danaher Description and Business Overview

Table 63. Danaher Infectious Disease In-vitro Diagnostic Products, Services and Solutions

Table 64. Revenue (US$ Million) in Infectious Disease In-vitro Diagnostic Business of Danaher (2019-2024)

Table 65. Danaher Recent Developments

Table 66. QIAGEN Basic Information List

Table 67. QIAGEN Description and Business Overview

Table 68. QIAGEN Infectious Disease In-vitro Diagnostic Products, Services and Solutions

Table 69. Revenue (US$ Million) in Infectious Disease In-vitro Diagnostic Business of QIAGEN (2019-2024)

Table 70. QIAGEN Recent Developments

Table 71. Roche Basic Information List

Table 72. Roche Description and Business Overview

Table 73. Roche Infectious Disease In-vitro Diagnostic Products, Services and Solutions

Table 74. Revenue (US$ Million) in Infectious Disease In-vitro Diagnostic Business of Roche (2019-2024)

Table 75. Roche Recent Developments

Table 76. Siemens Healthineers AG Basic Information List

Table 77. Siemens Healthineers AG Description and Business Overview

Table 78. Siemens Healthineers AG Infectious Disease In-vitro Diagnostic Products, Services and Solutions

Table 79. Revenue (US$ Million) in Infectious Disease In-vitro Diagnostic Business of Siemens Healthineers AG (2019-2024)

Table 80. Siemens Healthineers AG Recent Developments

Table 81. Bio-Rad Laboratories, Inc. Basic Information List

Table 82. Bio-Rad Laboratories, Inc. Description and Business Overview

Table 83. Bio-Rad Laboratories, Inc. Infectious Disease In-vitro Diagnostic Products, Services and Solutions

Table 84. Revenue (US$ Million) in Infectious Disease In-vitro Diagnostic Business of Bio-Rad Laboratories, Inc. (2019-2024)

Table 85. Bio-Rad Laboratories, Inc. Recent Developments

Table 86. Key Raw Materials Lists

Table 87. Raw Materials Key Suppliers Lists

Table 88. Infectious Disease In-vitro Diagnostic Downstream Customers

Table 89. Infectious Disease In-vitro Diagnostic Distributors List

Table 90. Research Programs/Design for This Report

Table 91. Key Data Information from Secondary Sources

Table 92. Key Data Information from Primary Sources

Table 93. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Infectious Disease In-vitro Diagnostic Product Picture

Figure 2. Global Infectious Disease In-vitro Diagnostic Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Infectious Disease In-vitro Diagnostic Sales Value (2019-2030) & (US$ Million)

Figure 4. Infectious Disease In-vitro Diagnostic Report Years Considered

Figure 5. Global Infectious Disease In-vitro Diagnostic Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Infectious Disease In-vitro Diagnostic Revenue in 2023

Figure 7. Infectious Disease In-vitro Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Immunoassay Picture

Figure 9. Molecular Diagnostics Picture

Figure 10. Microbiology Picture

Figure 11. Others Picture

Figure 12. Global Infectious Disease In-vitro Diagnostic Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 13. Global Infectious Disease In-vitro Diagnostic Sales Value Market Share by Type, 2023 & 2030

Figure 14. Product Picture of COVID-19

Figure 15. Product Picture of MRSA

Figure 16. Product Picture of Clostridium Difficile

Figure 17. Product Picture of Respiratory Virus

Figure 18. Product Picture of TB and Drug-resistant TB

Figure 19. Product Picture of Chlamydia

Figure 20. Product Picture of Gonorrhea

Figure 21. Product Picture of HPV

Figure 22. Product Picture of HIV

Figure 23. Product Picture of Others(Gastro-intestinal Panel Testing, Hepatitis C, Hepatitis B, etc)

Figure 24. Global Infectious Disease In-vitro Diagnostic Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 25. Global Infectious Disease In-vitro Diagnostic Sales Value Market Share by Application, 2023 & 2030

Figure 26. North America Infectious Disease In-vitro Diagnostic Sales Value (2019-2030) & (US$ Million)

Figure 27. North America Infectious Disease In-vitro Diagnostic Sales Value by Country (%), 2023 VS 2030

Figure 28. Europe Infectious Disease In-vitro Diagnostic Sales Value (2019-2030) & (US$ Million)

Figure 29. Europe Infectious Disease In-vitro Diagnostic Sales Value by Country (%), 2023 VS 2030

Figure 30. Asia Pacific Infectious Disease In-vitro Diagnostic Sales Value (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Infectious Disease In-vitro Diagnostic Sales Value by Country (%), 2023 VS 2030

Figure 32. South America Infectious Disease In-vitro Diagnostic Sales Value (2019-2030) & (US$ Million)

Figure 33. South America Infectious Disease In-vitro Diagnostic Sales Value by Country (%), 2023 VS 2030

Figure 34. Middle East & Africa Infectious Disease In-vitro Diagnostic Sales Value (2019-2030) & (US$ Million)

Figure 35. Middle East & Africa Infectious Disease In-vitro Diagnostic Sales Value by Country (%), 2023 VS 2030

Figure 36. Key Countries/Regions Infectious Disease In-vitro Diagnostic Sales Value (%), (2019-2030)

Figure 37. United States Infectious Disease In-vitro Diagnostic Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Infectious Disease In-vitro Diagnostic Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Infectious Disease In-vitro Diagnostic Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Infectious Disease In-vitro Diagnostic Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Infectious Disease In-vitro Diagnostic Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Infectious Disease In-vitro Diagnostic Sales Value by Application (%), 2023 VS 2030

Figure 43. China Infectious Disease In-vitro Diagnostic Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Infectious Disease In-vitro Diagnostic Sales Value by Type (%), 2023 VS 2030

Figure 45. China Infectious Disease In-vitro Diagnostic Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Infectious Disease In-vitro Diagnostic Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Infectious Disease In-vitro Diagnostic Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Infectious Disease In-vitro Diagnostic Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Infectious Disease In-vitro Diagnostic Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Infectious Disease In-vitro Diagnostic Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Infectious Disease In-vitro Diagnostic Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Infectious Disease In-vitro Diagnostic Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Infectious Disease In-vitro Diagnostic Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Infectious Disease In-vitro Diagnostic Sales Value by Application (%), 2023 VS 2030

Figure 55. India Infectious Disease In-vitro Diagnostic Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Infectious Disease In-vitro Diagnostic Sales Value by Type (%), 2023 VS 2030

Figure 57. India Infectious Disease In-vitro Diagnostic Sales Value by Application (%), 2023 VS 2030

Figure 58. Infectious Disease In-vitro Diagnostic Industrial Chain

Figure 59. Infectious Disease In-vitro Diagnostic Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-27Q18371

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Absorbable Microneedles - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-8V15090

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global Medical Heat Shrinkable Tubing Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-28O7342

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Disposable Hydrophilic Coated Guide Wire - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-30E18375

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Infectious Disease In-vitro Diagnostic - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: November 2024

Report Code: QYRE-Auto-24D9888

Infectious Disease In-vitro Diagnostic - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

FEATURED COMPANIES

Infectious Disease In-vitro Diagnostic - Market Size

Infectious Disease In-vitro Diagnostic - Market

Report Scope

Scope of Infectious Disease In-vitro Diagnostic - Market Report

Chapter Outline

FAQ for this report

What is the Infectious Disease In-vitro Diagnostic - Market size in 2030?

Who are the main players in the Infectious Disease In-vitro Diagnostic - Market report?

What are the Application segmentation covered in the Infectious Disease In-vitro Diagnostic - Market report?

What are the Type segmentation covered in the Infectious Disease In-vitro Diagnostic - Market report?

FEATURED COMPANIES

RELATED REPORTS